NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

電刀(電藥)和生物電子藥物的全球市場(~2026):產品(起搏器、ICD、人工耳蝸、深部腦、脊髓、迷走神經、□神經刺激器)□類型(嵌入式/非侵入性)□最終用戶□按地區

Electroceuticals/Bioelectric Medicine Market by Product (Pacemaker, ICD, Cochlear Implant, Deep Brain, Spinal Cord, Vagus, Sacral Nerve Stimulators), Application (Ischemia, Epilepsy), Type (Implantable, Noninvasive), End User - Global Forecast to 2026

出版商 MarketsandMarkets 商品編碼 1015131
出版日期 內容資訊 英文 255 Pages
訂單完成後即時交付
價格
電刀(電藥)和生物電子藥物的全球市場(~2026):產品(起搏器、ICD、人工耳蝸、深部腦、脊髓、迷走神經、□神經刺激器)□類型(嵌入式/非侵入性)□最終用戶□按地區 Electroceuticals/Bioelectric Medicine Market by Product (Pacemaker, ICD, Cochlear Implant, Deep Brain, Spinal Cord, Vagus, Sacral Nerve Stimulators), Application (Ischemia, Epilepsy), Type (Implantable, Noninvasive), End User - Global Forecast to 2026
出版日期: 2021年06月18日內容資訊: 英文 255 Pages
簡介

在預測期內,全球電工和生物電子市場將以 5.0% 的複合年增長率增長,從 2021 年的 168 億美元增長到 2026 年的 215 億美元。預計將增長到美元。

增加對 CRM 設備研究的投資和資金、增加政府對神經病的支持和資金、人口老齡化加劇以及相關的神經病和心血管疾病患病率增加。我們正在推動市場的增長。另一方面,電刀設備的高成本和大規模的資本投資要求是市場進一步增長的主要障礙。

從產品來看,人工耳蝸部門增長最快。聽力損失的增加正在推動該行業的增長。對於最終用戶,醫院、診所和門診中心預計將以最大的複合年增長率增長。

本報告探討了全球電子製藥和生物電子市場、市場定義和概述、價值鏈、新型冠狀病毒感染 (COVID-19) 和其他市場影響因素分析、法律和監管環境、技術/專利分析、市場規模轉變/預測、產品/用途/類型/最終用戶/地區/主要國家細分、競爭環境、主要公司概況等..

第 1 章介紹

第二章調查方法

第 3 章執行摘要

第 4 章重要考慮事項

第 5 章市場概覽

  • 市場動態
    • 促進因素
    • 抑製器
    • 市場機會
    • 挑戰
  • COVID-19 的影響
  • 範圍/場景
  • 價格分析
  • 專利分析
  • 貿易分析
  • 價值鏈分析
  • 供應鏈分析
  • 生態系統
  • 波特五力分析
  • 監管狀態
  • 技術分析
  • 影響客戶業務的趨勢

第 6 章市場分析/預測:按產品

  • 心臟起搏器/植入式心律轉復除顫器
  • 脊髓刺激器
    • 慢性疼痛
    • FBSS(脊柱後疼痛綜合徵)
    • 腦缺血
  • 人工耳蝸
  • 深部腦刺激器
    • 帕金森病
    • 震顫
    • 抑鬱症
    • 其他
  • □神經刺激器/胃電刺激器
    • 尿失禁
    • 胃輕癱
    • 大便失禁
  • 經皮神經電刺激器
    • 難治性抑鬱症
    • 其他
  • 迷走神經刺激器
    • 癲癇
    • 其他
  • 其他

第 7 章市場分析/預測:按類型

  • 嵌入式電氣設備
  • 非侵入性電氣設備

第 8 章市場分析/預測:按最終用戶

  • 醫院/診所/門診中心
  • 其他

第 9 章市場分析/預測:按地區/主要國家

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 其他
  • 拉丁美洲
  • 中東/非洲

第10章競爭形勢

  • 概述
  • 大公司的戰略
  • 主要公司的收入份額分析
  • 市場份額分析
  • 企業評估象限
  • 初創企業/中小企業:競爭領導力圖
  • 競爭基準
  • 競爭場景

第 11 章公司簡介

  • 主要公司
    • MEDTRONIC PLC
    • ABBOTT LABORATORIES, INC.
    • BOSTON SCIENTIFIC CORPORATION
    • COCHLEAR LTD.
    • LIVANOVA PLC
    • MICROPORT SCIENTIFIC CORPORATION
    • SONOVA GROUP
    • NEVRO CORP.
    • AXONICS MODULATION TECHNOLOGIES, INC.
    • SECOND SIGHT MEDICAL PRODUCTS, INC.
  • 其它有力企業
    • NEURONETICS, INC.
    • NEUROPACE, INC.
    • BIOTRONIK
    • MEDICO S.P.A.
    • NUROTRON BIOTECHNOLOGY CO. LTD.
    • MED-EL
    • ALEVA NEUROTHERAPEUTICS SA
    • NEUROSIGMA, INC.
    • BIOWAVE CORPORATION
    • SOTERIX MEDICAL INC.
    • BIOINDUCTION LTD
    • GIMER MEDICAL
    • CEFALY
    • BIOCONTROL MEDICAL
    • TVNS TECHNOLOGIES GMBH

第12章 附錄

目錄
Product Code: MD 4358

The global electroceuticals/bioelectric medicine market is projected to reach USD 21.5 billion by 2026 from USD 16.8 billion in 2021, at a CAGR of 5.0% during the forecast period. Market growth is driven by factors such as the increasing investments and funding for research on CRM devices, rising government support & funding for neurological disorders, and the rising geriatric population and subsequent growth in the prevalence of neurological & cardiovascular disorders. On the other hand, the high cost of electroceutical devices and the requirement of high capital investments are the major factors hampering the growth of this market.

"The cochlear implantssegment accounted for the highest growth rate in theelectroceuticalsmarket, by product, during the forecast period"

Theelectroceuticals market is segmented into cardiac pacemakers & implantable cardioverter defibrillators, spinal cord stimulators, cochlear implants, deep brain stimulators, transcutaneous electrical nerve stimulators, vagus nerve stimulators, sacral nerve stimulators & gastric electrical stimulators, and other electrical stimulators based on product. In 2020, the cochlear implants segment accounted for the highest growth rate in the electroceuticals market.The increasing prevalence of hearing lossis a major factor contributing to the growth of this segment.

"Hospitals, clinics, and ASCs segment accounted for the highest CAGR"

Based on end users, the electroceuticals market is segmented into hospitals, clinics, and ASCs; and other end users. In 2020, the hospitals, clinics, and ASCs segment accounted for the highest growth rate. This can be attributed to theincreasing adoption of electroceutical devices to serve a large patient pool.

"Asia Pacific: The fastest-growing regionelectroceuticals market"

The global electroceuticals market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is projected to register the highest CAGR during the forecast period.Factors such as the rising healthcare spending, increasing pharmaceutical research funding, increasing government efforts to increase awareness about early disease detection, expansion of private-sector hospitals to rural areas in various APAC countries, and the presence of high-growth markets in the region are driving the growth of the electroceuticals market in this region.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1 - 40%, Tier 2 - 30%,and Tier 3 -30%
  • By Designation: C-level - 27%, D-level - 18%, and Others - 55%
  • By Region: North America -51%, Europe - 21%, Asia Pacific - 18%, Latin America - 6%, and the Middle East & Africa - 4%

Lists of Companies Profiled in the Report:

  • Medtronic plc (Ireland)
  • Boston Scientific Corporation (US)
  • Abbott Laboratories, Inc. (US)
  • LivaNova PLC (UK)
  • Cochlear Ltd. (Australia)
  • MicroPort Scientific Corporation (China)
  • Sonova Group (Switzerland)
  • Nevro Corp. (US)
  • Axonics Modulation Technologies, Inc. (US)
  • Neuronetics, Inc. (US)
  • Second Sight Medical Products, Inc. (US)
  • NeuroPace, Inc. (US)
  • BIOTRONIK (Germany)
  • Medico S.p.A. (Italy)
  • Nurotron Biotechnology Co. Ltd. (US)
  • MED-EL (Austria)
  • AlevaNeurotherapeutics SA (Switzerland)
  • NeuroSigma, Inc. (US)
  • BioWave Corporation (US)
  • Soterix Medical Inc. (US)
  • Bioinduction Ltd. (UK)
  • GiMer Medical (Taiwan)
  • Cefaly (Belgium)
  • BioControl Medical (Israel)
  • tVNS Technologies GmbH (Germany)

Research Coverage:

This report provides a detailed picture of the global electroceuticalsmarket. It aims at estimating the size and future growth potential of the market across different segments, such as product, type, end user,and region. The report also includes an in-depth competitive analysis ofthe key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall electroceuticals market and its subsegments.It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
    • 1.2.2 MARKETS COVERED
    • FIGURE 1 ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET SEGMENTATION
    • 1.2.3 YEARS CONSIDERED FOR THE STUDY
  • 1.3 CURRENCY
  • 1.4 LIMITATIONS
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
  • 2.2 RESEARCH APPROACH
    • FIGURE 2 ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET: RESEARCH DESIGN
    • 2.2.1 SECONDARY DATA
      • 2.2.1.1 Key data from secondary sources
    • 2.2.2 PRIMARY DATA
      • 2.2.2.1 Key data from primary sources
      • 2.2.2.2 Key industry insights
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.3 MARKET SIZE ESTIMATION
    • 2.3.1 BOTTOM-UP APPROACH
      • 2.3.1.1 Company revenue estimation approach
    • FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
      • 2.3.1.2 Segmental revenue estimation approach
    • FIGURE 5 BOTTOM-UP APPROACH: SEGMENTAL REVENUE ESTIMATION APPROACH
      • 2.3.1.3 CAGR projections
    • FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
    • 2.3.2 TOP-DOWN APPROACH
    • FIGURE 7 ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET: TOP-DOWN APPROACH
  • 2.4 MARKET BREAKDOWN & DATA TRIANGULATION
    • FIGURE 8 DATA TRIANGULATION METHODOLOGY
  • 2.5 ASSUMPTIONS FOR THE STUDY
  • 2.6 GROWTH RATE ASSUMPTIONS
  • 2.7 LIMITATIONS
  • 2.8 RISK ASSESSMENT
    • 2.8.1 RISKS ASSESSMENT
  • 2.9 COVID-19 HEALTH ASSESSMENT
  • 2.10 COVID-19 ECONOMIC ASSESSMENT
  • 2.11 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
    • FIGURE 9 CRITERIA IMPACTING THE GLOBAL ECONOMY
    • FIGURE 10 RECOVERY SCENARIO OF THE GLOBAL ECONOMY
  • 2.12 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ELECTROCEUTICALS/ BIOELECTRIC MEDICINE MARKET

3 EXECUTIVE SUMMARY

    • FIGURE 11 ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
    • FIGURE 12 ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 13 ELECTROCEUTICALS MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
    • FIGURE 14 ELECTROCEUTICALS MARKET, BY REGION, 2021 VS. 2026 (USD MILLION)

4 PREMIUM INSIGHTS

  • 4.1 ELECTROCEUTICALS MARKET OVERVIEW
    • FIGURE 15 RISING PREVALENCE OF CARDIOVASCULAR & NEUROLOGICAL DISORDERS TO DRIVE THE MARKET GROWTH
  • 4.2 ELECTROCEUTICALS MARKET SHARE, BY PRODUCT, 2021 VS. 2026
    • FIGURE 16 CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN 2026
  • 4.3 ELECTROCEUTICALS MARKET SHARE, BY TYPE, 2021 VS. 2026
    • FIGURE 17 IMPLANTABLE ELECTROCEUTICAL DEVICES SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
  • 4.4 ELECTROCEUTICALS MARKET SHARE, BY END USER, 2021 VS. 2026
    • FIGURE 18 HOSPITALS, CLINICS, AND ASCS TO CONTINUE TO DOMINATE THE MARKET IN 2026
  • 4.5 ELECTROCEUTICALS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 19 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH RATE IN THE ELECTROCEUTICALS MARKET DURING THE FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 20 ELECTROCEUTICALS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising geriatric population and subsequent growth in the prevalence of neurological & cardiovascular disorders
      • 5.2.1.2 Rising government support & funding for neurological disorders
    • FIGURE 21 FUNDING FOR RESEARCH BY THE NATIONAL INSTITUTES OF HEALTH (US)
      • 5.2.1.3 Increasing investments and funding for research on CRM devices
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High cost of electroceutical devices
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Emerging markets
    • 5.2.4 CHALLENGES
      • 5.2.4.1 The dearth of trained professionals
      • 5.2.4.2 Challenges associated with battery life and device replacement
  • 5.3 IMPACT OF COVID-19 ON THE ELECTROCEUTICALS/ BIOELECTRIC MEDICINE MARKET
  • 5.4 RANGES/ SCENARIOS
    • 5.4.1 ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET
    • FIGURE 22 DEPENDING ON UNCERTAINTIES, THE FOLLOWING SCENARIOS HAVE BEEN ASSESSED FOR THE ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET
  • 5.5 PRICING ANALYSIS
    • TABLE 1 PRICE OF ELECTROCEUTICAL DEVICES (2021)
  • 5.6 PATENT ANALYSIS
    • 5.6.1 PATENT ANALYSIS OF CARDIAC PACEMAKERS
    • 5.6.2 PATENT ANALYSIS OF COCHLEAR IMPLANTS
  • 5.7 TRADE ANALYSIS
    • 5.7.1 TRADE ANALYSIS FOR PACEMAKERS
    • TABLE 2 IMPORT DATA FOR PACEMAKERS, BY COUNTRY, 2016-2020 (USD MILLION)
    • TABLE 3 EXPORT DATA FOR PACEMAKERS, BY COUNTRY, 2016-2020 (USD MILLION)
  • 5.8 VALUE CHAIN ANALYSIS
    • FIGURE 23 MAJOR VALUE IS ADDED DURING THE MANUFACTURING & ASSEMBLY PHASE
  • 5.9 SUPPLY CHAIN ANALYSIS
    • FIGURE 24 DISTRIBUTION-A STRATEGY PREFERRED BY PROMINENT COMPANIES
  • 5.10 ECOSYSTEM ANALYSIS OF THE ELECTROCEUTICALS/ BIOELECTRIC MEDICINE MARKET
    • FIGURE 25 ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET: ECOSYSTEM ANALYSIS
    • 5.10.1 ROLE IN ECOSYSTEM
  • 5.11 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 4 ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.11.1 THREAT OF NEW ENTRANTS
    • 5.11.2 THREAT OF SUBSTITUTES
    • 5.11.3 BARGAINING POWER OF BUYERS
    • 5.11.4 BARGAINING POWER OF SUPPLIERS
    • 5.11.5 DEGREE OF COMPETITION
  • 5.12 REGULATORY LANDSCAPE
    • 5.12.1 NORTH AMERICA
      • 5.12.1.1 US
      • 5.12.1.2 Canada
    • 5.12.2 EUROPE
    • 5.12.3 ASIA PACIFIC
      • 5.12.3.1 Japan
      • 5.12.3.2 India
    • 5.12.4 LATIN AMERICA
      • 5.12.4.1 Brazil
      • 5.12.4.2 Mexico
    • 5.12.5 MIDDLE EAST
  • 5.13 TECHNOLOGY ANALYSIS
  • 5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
    • 5.14.1 REVENUE SHIFT & REVENUE POCKETS FOR ELECTROCEUTICAL DEVICES MANUFACTURERS
    • 5.14.2 REVENUE SHIFT FOR ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET

6 ELECTROCEUTICALS MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
    • TABLE 5 ELECTROCEUTICALS MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 6 ELECTROCEUTICALS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
  • 6.2 CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
    • 6.2.1 INTRODUCTION OF LEADLESS AND MRI-SAFE CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS TO BOOST THE MARKET GROWTH OF THIS SEGMENT
    • TABLE 7 KEY PRODUCTS IN THE CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET
    • TABLE 8 CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 9 CARDIAC PACEMAKERS & IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2020-2026 (USD MILLION)
  • 6.3 SPINAL CORD STIMULATORS
    • TABLE 10 KEY PRODUCTS IN THE SPINAL CORD STIMULATORS MARKET
    • TABLE 11 SPINAL CORD STIMULATORS MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 12 SPINAL CORD STIMULATORS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • 6.3.1 CHRONIC PAIN
      • 6.3.1.1 Spinal cord stimulation (SCS) is the standard procedure for patients with chronic pain in the back and limbs
    • TABLE 13 SPINAL CORD STIMULATORS MARKET FOR CHRONIC PAIN, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 14 SPINAL CORD STIMULATORS MARKET FOR CHRONIC PAIN, BY REGION, 2020-2026 (USD MILLION)
    • 6.3.2 FAILED BACK SURGERY SYNDROME
      • 6.3.2.1 Introduction of alternative therapies to restrain the market growth
    • TABLE 15 SPINAL CORD STIMULATORS MARKET FOR FAILED BACK SURGERY SYNDROME, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 16 SPINAL CORD STIMULATORS MARKET FOR FAILED BACK SURGERY SYNDROME, BY REGION, 2020-2026 (USD MILLION)
    • 6.3.3 CEREBRAL ISCHEMIA
      • 6.3.3.1 High incidence of ischemia to drive the market growth for spinal cord stimulators
    • TABLE 17 SPINAL CORD STIMULATORS MARKET FOR CEREBRAL ISCHEMIA, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 18 SPINAL CORD STIMULATORS MARKET FOR CEREBRAL ISCHEMIA, BY REGION, 2020-2026 (USD MILLION)
  • 6.4 COCHLEAR IMPLANTS
    • 6.4.1 INCREASING PREVALENCE OF HEARING LOSS TO DRIVE THE MARKET DEMAND FOR COCHLEAR IMPLANTS
    • TABLE 19 KEY DEVICES IN THE COCHLEAR IMPLANTS MARKET
    • TABLE 20 COCHLEAR IMPLANTS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 21 COCHLEAR IMPLANTS MARKET, BY REGION, 2020-2026 (USD MILLION)
  • 6.5 DEEP BRAIN STIMULATORS
    • TABLE 22 KEY DEVICES IN THE DEEP BRAIN STIMULATORS MARKET
    • TABLE 23 DEEP BRAIN STIMULATORS MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 24 DEEP BRAIN STIMULATORS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • 6.5.1 PARKINSON'S DISEASE
      • 6.5.1.1 The rising incidence of Parkinson's disease and growing R&D activities in this field is likely to drive market growth
    • TABLE 25 DEEP BRAIN STIMULATORS MARKET FOR PARKINSON'S DISEASE, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 26 DEEP BRAIN STIMULATORS MARKET FOR PARKINSON'S DISEASE, BY REGION, 2020-2026 (USD MILLION)
    • 6.5.2 TREMORS
      • 6.5.2.1 The high efficiency of DBS in treating tremors has boosted the market demand for deep brain stimulators
    • TABLE 27 DEEP BRAIN STIMULATORS MARKET FOR TREMORS, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 28 DEEP BRAIN STIMULATORS MARKET FOR TREMORS, BY REGION, 2020-2026 (USD MILLION)
    • 6.5.3 DEPRESSION
      • 6.5.3.1 The use of DBS in the treatment of depression is restrained by a lack of evidence for its efficacy
    • TABLE 29 DEEP BRAIN STIMULATORS MARKET FOR DEPRESSION, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 30 DEEP BRAIN STIMULATORS MARKET FOR DEPRESSION, BY REGION, 2020-2026 (USD MILLION)
    • 6.5.4 OTHER DBS APPLICATIONS
    • TABLE 31 DEEP BRAIN STIMULATORS MARKET FOR OTHER DBS APPLICATIONS, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 32 DEEP BRAIN STIMULATORS MARKET FOR OTHER DBS APPLICATIONS, BY REGION, 2020-2026 (USD MILLION)
  • 6.6 SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS
    • TABLE 33 SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 34 SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • 6.6.1 URINARY INCONTINENCE
      • 6.6.1.1 High incidence of urinary incontinence to offer growth opportunities for sacral nerve stimulators
    • TABLE 35 SACRAL NERVE STIMULATORS MARKET FOR URINARY INCONTINENCE, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 36 SACRAL NERVE STIMULATORS MARKET FOR URINARY INCONTINENCE, BY REGION, 2020-2026 (USD MILLION)
    • 6.6.2 GASTROPARESIS
      • 6.6.2.1 Gastric electrical stimulation treatment reduces the hospital stay duration for patients affected by gastroparesis
    • TABLE 37 GASTRIC ELECTRICAL STIMULATORS MARKET FOR GASTROPARESIS, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 38 GASTRIC ELECTRICAL STIMULATORS MARKET FOR GASTROPARESIS, BY REGION, 2020-2026 (USD MILLION)
    • 6.6.3 FECAL INCONTINENCE
      • 6.6.3.1 High reductions in symptom recurrence have supported the use of sacral nerve stimulators in fecal incontinence treatment
    • TABLE 39 SACRAL NERVE STIMULATORS MARKET FOR FECAL INCONTINENCE, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 40 SACRAL NERVE STIMULATORS MARKET FOR FECAL INCONTINENCE, BY REGION, 2020-2026 (USD MILLION)
  • 6.7 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS
    • TABLE 41 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 42 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • 6.7.1 TREATMENT-RESISTANT DEPRESSION
      • 6.7.1.1 High prevalence of depression to support the market growth
    • TABLE 43 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR TREATMENT-RESISTANT DEPRESSION, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 44 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR TREATMENT-RESISTANT DEPRESSION, BY REGION, 2020-2026 (USD MILLION)
    • 6.7.2 OTHER TENS APPLICATIONS
    • TABLE 45 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR OTHER TENS APPLICATIONS, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 46 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET FOR OTHER TENS APPLICATIONS, BY REGION, 2020-2026 (USD MILLION)
  • 6.8 VAGUS NERVE STIMULATORS
    • TABLE 47 VAGUS NERVE STIMULATORS MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 48 VAGUS NERVE STIMULATORS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • 6.8.1 EPILEPSY
      • 6.8.1.1 Advantages associated with VNS in the treatment of epilepsy are expected to drive the market growth
    • TABLE 49 VAGUS NERVE STIMULATORS MARKET FOR EPILEPSY, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 50 VAGUS NERVE STIMULATORS MARKET FOR EPILEPSY, BY REGION, 2020-2026 (USD MILLION)
    • 6.8.2 OTHER VNS APPLICATIONS
    • TABLE 51 VAGUS NERVE STIMULATORS MARKET FOR OTHER VNS APPLICATIONS, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 52 VAGUS NERVE STIMULATORS MARKET FOR OTHER VNS APPLICATIONS, BY REGION, 2020-2026 (USD MILLION)
  • 6.9 OTHER ELECTRICAL STIMULATORS
    • TABLE 53 OTHER ELECTRICAL STIMULATORS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 54 OTHER ELECTRICAL STIMULATORS MARKET, BY REGION, 2020-2026 (USD MILLION)

7 ELECTROCEUTICALS MARKET, BY TYPE

  • 7.1 INTRODUCTION
    • TABLE 55 ELECTROCEUTICALS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 56 ELECTROCEUTICALS MARKET, BY TYPE, 2020-2026 (USD MILLION)
  • 7.2 IMPLANTABLE ELECTROCEUTICAL DEVICES
    • 7.2.1 LONG TERM COST SAVINGS ASSOCIATED WITH THE USE OF THESE DEVICES TO DRIVE THE MARKET GROWTH
    • TABLE 57 IMPLANTABLE ELECTROCEUTICAL DEVICES MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 58 IMPLANTABLE ELECTROCEUTICAL DEVICES MARKET, BY REGION, 2020-2026 (USD MILLION)
  • 7.3 NONINVASIVE ELECTROCEUTICAL DEVICES
    • 7.3.1 EXTENSIVE USE IN HEALTHCARE, EASE OF USE, AND LOW COSTS TO DRIVE THE MARKET GROWTH FOR NONINVASIVE DEVICES
    • TABLE 59 NONINVASIVE ELECTROCEUTICAL DEVICES MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 60 NONINVASIVE ELECTROCEUTICAL DEVICES MARKET, BY REGION, 2020-2026 (USD MILLION)

8 ELECTROCEUTICALS MARKET, BY END USER

  • 8.1 INTRODUCTION
    • TABLE 61 ELECTROCEUTICALS MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 62 ELECTROCEUTICALS MARKET, BY END USER, 2020-2026 (USD MILLION)
  • 8.2 HOSPITALS, CLINICS, AND ASCS
    • 8.2.1 GROWING NUMBER OF SURGERIES PERFORMED IN HOSPITALS AND ASCS TO SUPPORT THE MARKET GROWTH
    • TABLE 63 ELECTROCEUTICALS MARKET FOR HOSPITALS, CLINICS, AND ASCS, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 64 ELECTROCEUTICALS MARKET FOR HOSPITALS, CLINICS, AND ASCS, BY REGION, 2020-2026 (USD MILLION)
  • 8.3 OTHER END USERS
    • TABLE 65 ELECTROCEUTICALS MARKET FOR OTHER END USERS, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 66 ELECTROCEUTICALS MARKET FOR OTHER END USERS, BY REGION, 2020-2026 (USD MILLION)

9 ELECTROCEUTICALS MARKET, BY REGION

  • 9.1 INTRODUCTION
    • TABLE 67 ELECTROCEUTICALS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 68 ELECTROCEUTICALS MARKET, BY REGION, 2020-2026 (USD MILLION)
  • 9.2 NORTH AMERICA
    • FIGURE 26 NORTH AMERICA: ELECTROCEUTICALS MARKET SNAPSHOT
    • TABLE 69 NORTH AMERICA: ELECTROCEUTICALS MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
    • TABLE 70 NORTH AMERICA: ELECTROCEUTICALS MARKET, BY COUNTRY, 2020-2026 (USD MILLION)
    • TABLE 71 NORTH AMERICA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 72 NORTH AMERICA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • 9.2.1 US
      • 9.2.1.1 The US dominated the North American electroceuticals market in 2020
    • TABLE 73 US: KEY MACROINDICATORS
    • TABLE 74 US: ELECTROCEUTICALS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 75 US: ELECTROCEUTICALS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 76 US: ELECTROCEUTICALS MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 77 US: ELECTROCEUTICALS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 78 US: SPINAL CORD STIMULATORS MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 79 US: SPINAL CORD STIMULATORS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 80 US: DEEP BRAIN STIMULATORS MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 81 US: DEEP BRAIN STIMULATORS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 82 US: SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 83 US: SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 84 US: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 85 US: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 86 US: VAGUS NERVE STIMULATORS MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 87 US: VAGUS NERVE STIMULATORS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 88 US: ELECTROCEUTICALS MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 89 US: ELECTROCEUTICALS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 9.2.2 CANADA
      • 9.2.2.1 Favorable environment for R&D in cardiology and neurosciences to drive the market growth
    • TABLE 90 NEUROLOGICAL CONDITIONS IN CANADA
    • TABLE 91 CANADA: ELECTROCEUTICALS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 92 CANADA: ELECTROCEUTICALS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 93 CANADA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 94 CANADA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 95 CANADA: SPINAL CORD STIMULATORS MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 96 CANADA: SPINAL CORD STIMULATORS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 97 CANADA: DEEP BRAIN STIMULATORS MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 98 CANADA: DEEP BRAIN STIMULATORS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 99 CANADA: SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 100 CANADA: SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 101 CANADA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 102 CANADA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 103 CANADA: VAGUS NERVE STIMULATORS MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 104 CANADA: VAGUS NERVE STIMULATORS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 105 CANADA: ELECTROCEUTICALS MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 106 CANADA: ELECTROCEUTICALS MARKET, BY END USER, 2020-2026 (USD MILLION)
  • 9.3 EUROPE
    • TABLE 107 EUROPE: ELECTROCEUTICALS MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
    • TABLE 108 EUROPE: ELECTROCEUTICALS MARKET, BY COUNTRY, 2020-2026 (USD MILLION)
    • TABLE 109 EUROPE: ELECTROCEUTICALS MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 110 EUROPE: ELECTROCEUTICALS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • 9.3.1 GERMANY
      • 9.3.1.1 Germany dominated the European electroceuticals market in 2020
    • TABLE 111 GERMANY: KEY MACROINDICATORS
    • TABLE 112 GERMANY: ELECTROCEUTICALS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 113 GERMANY: ELECTROCEUTICALS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 114 GERMANY: ELECTROCEUTICALS MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 115 GERMANY: ELECTROCEUTICALS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 116 GERMANY: SPINAL CORD STIMULATORS MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 117 GERMANY: SPINAL CORD STIMULATORS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 118 GERMANY: DEEP BRAIN STIMULATORS MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 119 GERMANY: DEEP BRAIN STIMULATORS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 120 GERMANY: SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 121 GERMANY: SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 122 GERMANY: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 123 GERMANY: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 124 GERMANY: VAGUS NERVE STIMULATORS MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 125 GERMANY: VAGUS NERVE STIMULATORS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 126 GERMANY: ELECTROCEUTICALS MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 127 GERMANY: ELECTROCEUTICALS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 9.3.2 UK
      • 9.3.2.1 Increasing investments and funding by the government to drive the market growth in the UK
    • TABLE 128 UK: KEY MACROINDICATORS
    • TABLE 129 UK: ELECTROCEUTICALS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 130 UK: ELECTROCEUTICALS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 131 UK: ELECTROCEUTICALS MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 132 UK: ELECTROCEUTICALS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 133 UK: SPINAL CORD STIMULATORS MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 134 UK: SPINAL CORD STIMULATORS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 135 UK: DEEP BRAIN STIMULATORS MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 136 UK: DEEP BRAIN STIMULATORS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 137 UK: SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 138 UK: SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 139 UK: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 140 UK: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 141 UK: VAGUS NERVE STIMULATORS MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 142 UK: VAGUS NERVE STIMULATORS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 143 UK: ELECTROCEUTICALS MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 144 UK: ELECTROCEUTICALS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 9.3.3 REST OF EUROPE
    • TABLE 145 ROE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2018 (% OF GDP)
    • TABLE 146 ROE: ELECTROCEUTICALS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 147 ROE: ELECTROCEUTICALS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 148 ROE: ELECTROCEUTICALS MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 149 ROE: ELECTROCEUTICALS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 150 ROE: SPINAL CORD STIMULATORS MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 151 ROE: SPINAL CORD STIMULATORS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 152 ROE: DEEP BRAIN STIMULATORS MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 153 ROE: DEEP BRAIN STIMULATORS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 154 ROE: SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 155 ROE: SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 156 ROE: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 157 ROE: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 158 ROE: VAGUS NERVE STIMULATORS MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 159 ROE: VAGUS NERVE STIMULATORS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 160 ROE: ELECTROCEUTICALS MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 161 ROE: ELECTROCEUTICALS MARKET, BY END USER, BY APPLICATION, 2020-2026 (USD MILLION)
  • 9.4 ASIA PACIFIC
    • FIGURE 27 ASIA PACIFIC: ELECTROCEUTICALS MARKET SNAPSHOT
    • TABLE 162 APAC: ELECTROCEUTICALS MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
    • TABLE 163 APAC: ELECTROCEUTICALS MARKET, BY COUNTRY, 2020-2026 (USD MILLION)
    • TABLE 164 APAC: ELECTROCEUTICALS MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 165 APAC: ELECTROCEUTICALS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • 9.4.1 CHINA
      • 9.4.1.1 China dominated the APAC market for electroceutical devices in 2020
    • TABLE 166 CHINA: KEY MACROINDICATORS
    • TABLE 167 CHINA: ELECTROCEUTICALS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 168 CHINA: ELECTROCEUTICALS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 169 CHINA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 170 CHINA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 171 CHINA: SPINAL CORD STIMULATORS MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 172 CHINA: SPINAL CORD STIMULATORS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 173 CHINA: DEEP BRAIN STIMULATORS MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 174 CHINA: DEEP BRAIN STIMULATORS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 175 CHINA: SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 176 CHINA: SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 177 CHINA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 178 CHINA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 179 CHINA: VAGUS NERVE STIMULATORS MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 180 CHINA: VAGUS NERVE STIMULATORS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 181 CHINA: ELECTROCEUTICALS MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 182 CHINA: ELECTROCEUTICALS MARKET, BY END USER, BY APPLICATION, 2020-2026 (USD MILLION)
    • 9.4.2 JAPAN
      • 9.4.2.1 The elderly population in Japan drives the market growth for electroceutical devices
    • TABLE 183 JAPAN: KEY MACROINDICATORS
    • TABLE 184 JAPAN: ELECTROCEUTICALS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 185 JAPAN: ELECTROCEUTICALS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 186 JAPAN: ELECTROCEUTICALS MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 187 JAPAN: ELECTROCEUTICALS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 188 JAPAN: SPINAL CORD STIMULATORS MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 189 JAPAN: SPINAL CORD STIMULATORS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 190 JAPAN: DEEP BRAIN STIMULATORS MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 191 JAPAN: DEEP BRAIN STIMULATORS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 192 JAPAN: SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 193 JAPAN: SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 194 JAPAN: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 195 JAPAN: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 196 JAPAN: VAGUS NERVE STIMULATORS MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 197 JAPAN: VAGUS NERVE STIMULATORS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 198 JAPAN: ELECTROCEUTICALS MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 199 JAPAN: ELECTROCEUTICALS MARKET, BY END USER, BY APPLICATION, 2020-2026 (USD MILLION)
    • 9.4.3 REST OF ASIA PACIFIC
    • TABLE 200 ROAPAC: ELECTROCEUTICALS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 201 ROAPAC: ELECTROCEUTICALS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 202 ROAPAC: ELECTROCEUTICALS MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 203 ROAPAC: ELECTROCEUTICALS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 204 ROAPAC: SPINAL CORD STIMULATORS MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 205 ROAPAC: SPINAL CORD STIMULATORS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 206 ROAPAC: DEEP BRAIN STIMULATORS MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 207 ROAPAC: DEEP BRAIN STIMULATORS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 208 ROAPAC: SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 209 ROAPAC: SACRAL NERVE STIMULATORS & GASTRIC ELECTRICAL STIMULATORS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 210 ROAPAC: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 211 ROAPAC: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 212 ROAPAC: VAGUS NERVE STIMULATORS MARKET, BY APPLICATION, 2016-2019 (USD MILLION)
    • TABLE 213 ROAPAC: VAGUS NERVE STIMULATORS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 214 ROAPAC: ELECTROCEUTICALS MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 215 ROAPAC: ELECTROCEUTICALS MARKET, BY END USER, BY APPLICATION, 2020-2026 (USD MILLION)
  • 9.5 LATIN AMERICA
    • 9.5.1 INCREASING EFFORTS TO IMPLEMENT UNIVERSAL HEALTH COVERAGE IN THE REGION TO SUPPORT MARKET GROWTH
    • TABLE 216 LATIN AMERICA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 217 LATIN AMERICA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
  • 9.6 MIDDLE EAST & AFRICA
    • 9.6.1 STRENGTHENING OF HEALTHCARE INFRASTRUCTURE IN THE REGION TO SUPPORT THE MARKET GROWTH
    • TABLE 218 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2016-2019 (USD MILLION)
    • TABLE 219 MIDDLE EAST & AFRICA: ELECTROCEUTICALS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 10.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN THE ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET
    • TABLE 220 OVERVIEW OF STRATEGIES DEPLOYED BY KEY ELECTROCEUTICAL DEVICES MANUFACTURING COMPANIES
  • 10.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
    • FIGURE 28 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET
  • 10.4 MARKET SHARE ANALYSIS
    • FIGURE 29 ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET SHARE, BY KEY PLAYER (2020)
    • TABLE 221 ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET: DEGREE OF COMPETITION
  • 10.5 COMPANY EVALUATION QUADRANT
    • 10.5.1 LIST OF EVALUATED VENDORS
    • 10.5.2 STARS
    • 10.5.3 EMERGING LEADERS
    • 10.5.4 PERVASIVE PLAYERS
    • 10.5.5 PARTICIPANTS
    • FIGURE 30 ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020
  • 10.6 COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES (2020)
    • 10.6.1 PROGRESSIVE COMPANIES
    • 10.6.2 STARTING BLOCKS
    • 10.6.3 RESPONSIVE COMPANIES
    • 10.6.4 DYNAMIC COMPANIES
    • FIGURE 31 ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET: COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES, 2020
  • 10.7 COMPETITIVE BENCHMARKING
    • 10.7.1 PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS
    • FIGURE 32 PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS OF TOP PLAYERS IN THE ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET
    • TABLE 222 COMPANY PRODUCT TYPE FOOTPRINT
    • TABLE 223 COMPANY GEOGRAPHICAL FOOTPRINT
  • 10.8 COMPETITIVE SCENARIO
    • 10.8.1 PRODUCT LAUNCHES & REGULATORY APPROVALS
    • TABLE 224 KEY PRODUCT LAUNCHES & REGULATORY APPROVALS
    • 10.8.2 DEALS
    • TABLE 225 KEY DEALS

11 COMPANY PROFILES

  • 11.1 KEY PLAYERS

(Business Overview, Products Offered, Recent Developments, MnM view, Key strengths/right to win, Strategic choices made, Weaknesses and competitive threats)**

    • 11.1.1 MEDTRONIC PLC
    • TABLE 226 MEDTRONIC PLC: BUSINESS OVERVIEW
    • FIGURE 33 MEDTRONIC PLC: COMPANY SNAPSHOT (2020)
    • 11.1.2 ABBOTT LABORATORIES, INC.
    • TABLE 227 ABBOTT LABORATORIES, INC.: BUSINESS OVERVIEW
    • FIGURE 34 ABBOTT LABORATORIES, INC.: COMPANY SNAPSHOT (2020)
    • 11.1.3 BOSTON SCIENTIFIC CORPORATION
    • TABLE 228 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
    • FIGURE 35 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2020)
    • 11.1.4 COCHLEAR LTD.
    • TABLE 229 COCHLEAR LTD.: BUSINESS OVERVIEW
    • FIGURE 36 COCHLEAR LTD.: COMPANY SNAPSHOT (2020)
    • 11.1.5 LIVANOVA PLC
    • TABLE 230 LIVANOVA PLC: BUSINESS OVERVIEW
    • FIGURE 37 LIVANOVA PLC: COMPANY SNAPSHOT (2020)
    • 11.1.6 MICROPORT SCIENTIFIC CORPORATION
    • TABLE 231 MICROPORT SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
    • FIGURE 38 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2019)
    • 11.1.7 SONOVA GROUP
    • TABLE 232 SONOVA GROUP: BUSINESS OVERVIEW
    • FIGURE 39 SONOVA GROUP: COMPANY SNAPSHOT (2019)
    • 11.1.8 NEVRO CORP.
    • TABLE 233 NEVRO CORP.: BUSINESS OVERVIEW
    • FIGURE 40 NEVRO CORP.: COMPANY SNAPSHOT (2020)
    • 11.1.9 AXONICS MODULATION TECHNOLOGIES, INC.
    • TABLE 234 AXONICS MODULATION TECHNOLOGIES, INC.: BUSINESS OVERVIEW
    • FIGURE 41 AXONICS MODULATION TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2020)
    • 11.1.10 SECOND SIGHT MEDICAL PRODUCTS, INC.
    • TABLE 235 SECOND SIGHT MEDICAL PRODUCTS, INC.: BUSINESS OVERVIEW
    • FIGURE 42 SECOND SIGHT MEDICAL PRODUCTS, INC.: COMPANY SNAPSHOT (2019)
  • 11.2 OTHER PLAYERS
    • 11.2.1 NEURONETICS, INC.
    • TABLE 236 NEURONETICS, INC.: BUSINESS OVERVIEW
    • FIGURE 43 NEURONETICS, INC.: COMPANY SNAPSHOT (2020)
    • 11.2.2 NEUROPACE, INC.
    • TABLE 237 NEUROPACE, INC.: BUSINESS OVERVIEW
    • 11.2.3 BIOTRONIK
    • TABLE 238 BIOTRONIK: BUSINESS OVERVIEW
    • 11.2.4 MEDICO S.P.A.
    • TABLE 239 MEDICO S.P.A.: BUSINESS OVERVIEW
    • 11.2.5 NUROTRON BIOTECHNOLOGY CO. LTD.
    • TABLE 240 NUROTRON BIOTECHNOLOGY CO. LTD.: BUSINESS OVERVIEW
    • 11.2.6 MED-EL
    • TABLE 241 MED-EL: BUSINESS OVERVIEW
    • 11.2.7 ALEVA NEUROTHERAPEUTICS SA
    • TABLE 242 ALEVA NEUROTHERAPEUTICS SA: BUSINESS OVERVIEW
    • 11.2.8 NEUROSIGMA, INC.
  • ABLE 243 NEUROSIGMA, INC.: BUSINESS OVERVIEW
    • 11.2.9 BIOWAVE CORPORATION
    • TABLE 244 BIOWAVE CORPORATION: BUSINESS OVERVIEW
    • 11.2.10 SOTERIX MEDICAL INC.
    • TABLE 245 SOTERIX MEDICAL INC.: BUSINESS OVERVIEW
    • 11.2.11 BIOINDUCTION LTD
    • TABLE 246 BIOINDUCTION LTD: BUSINESS OVERVIEW
    • 11.2.12 GIMER MEDICAL
    • TABLE 247 GIMER MEDICAL: BUSINESS OVERVIEW
    • 11.2.13 CEFALY
    • TABLE 248 CEFALY: BUSINESS OVERVIEW
    • 11.2.14 BIOCONTROL MEDICAL
    • TABLE 249 BIOCONTROL MEDICAL: BUSINESS OVERVIEW
    • 11.2.15 TVNS TECHNOLOGIES GMBH
    • TABLE 250 TVNS TECHNOLOGIES GMBH: BUSINESS OVERVIEW
  • *Details on Business Overview, Products Offered, Recent Developments, MnM view, Key strengths/right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 INSIGHTS FROM INDUSTRY EXPERTS
  • 12.2 DISCUSSION GUIDE
  • 12.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.4 AVAILABLE CUSTOMIZATIONS
  • 12.5 RELATED REPORTS
  • 12.6 AUTHOR DETAILS